Rare diseases
Investigational molecules
Locations
Back to the Netherlands326 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Safety and tolerability of OV329 as add‑on therapy in adults with drug‑resistant focal epilepsy
The NetherlandsLow‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis
The NetherlandsELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
The NetherlandsPhase II/III trial of autologous dendritic cells loaded with allogenic mesothelioma lysate in patients with borderline resectable pancreatic cancer
The NetherlandsMicrodosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD
The NetherlandsStudy of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases
The NetherlandsPhase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma
The NetherlandsComparison of intrathecal baclofen pump and selective dorsal rhizotomy for children with cerebral palsy who cannot walk
The NetherlandsA study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer
The NetherlandsA Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy
The NetherlandsStudy on the Effects of D-Cycloserine and Brain Stimulation for Patients with Major Depressive Disorder
The NetherlandsStudy on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.
Particular emphasis on targeted therapies and treatment optimization for various cancer types.
Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.
Emphasis on developing effective long-term management strategies for chronic conditions.
Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.
Focus on improving patient outcomes through targeted interventions and preventive measures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
